Skip to main content

APIC25

Molecular diagnostics
Phoenix, Arizona | Americas

Join us for an enlightening session addressing the critical importance of early and accurate identification of Candida auris (C. auris). This pathogen has emerged as a global health concern and poses a significant threat to vulnerable patients. Delayed detection can lead to dangerous outbreaks in healthcare settings.

When: Tuesday, June 17, 2025

Time: 12:45–1:15 p.m.

Location: Exhibitor Theater - Booth #1937

Speaker: Sarah Elliott, PhD, Principal Scientist, Scientific Affairs

 

Protecting Patients: Molecular Detection of Candida auris Colonization using the Simplexa® C. auris Direct assay

Dr. Elliott will discuss the novel Simplexa® C. auris Direct assay—the first FDA De Novo granted molecular diagnostic test designed for the rapid and reliable detection of C. auris in patients suspected of colonization. Discover how this test can support your infection control strategies, safeguard patient health, and help prevent potentially deadly outbreaks.

Don't miss this opportunity to learn how Simplexa® C. auris Direct can play a pivotal role in combating the spread of C. auris and protecting our communities.  

Calendar
From 16 June 2025 - 12:01 AM (UTC)
To 18 June 2025
Event will start in
Days
:
Hours
:
Minutes
Share this event
Share this event